Psoriasis Treatment Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Market Dynamics of Psoriasis Treatment Market Analysis

↑ Growth Drivers

  • Advancements in biologic therapies and targeted treatments are expanding the treatment options available
  • Rising awareness and early diagnosis are encouraging more patients to seek psoriasis management
  • Growing adoption of personalized medicine is improving treatment efficacy and patient outcomes

↓ Restraints

  • High treatment costs limit accessibility for patients, especially in low-income regions
  • Side effects of some therapies, including biologics, discourage patient adherence and treatment continuity

~ Trends

  • The increasing use of biologics and targeted therapies is revolutionizing psoriasis treatment, offering more personalized options
  • A growing shift toward combination therapies to improve treatment outcomes and reduce side effects in psoriasis management

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Psoriasis Treatment Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Globalxxxx$ 32457 Million$ 71624.4 Million10.4%
North Americaxxxx$ 12009.1 Million$ 23636.1 Million8.8%
United Statesxxxx$ 9475.17 Millionxxxx8.6%
Canadaxxxx$ 1441.09 Millionxxxx9.6%
Mexicoxxxx$ 1092.83 Millionxxxx9.3%
Europexxxx$ 9412.53 Million$ 19338.6 Million9.4%
United Kingdomxxxx$ 1581.31 Millionxxxx10.2%
Francexxxx$ 865.95 Millionxxxx8.6%
Germanyxxxx$ 1863.68 Millionxxxx9.6%
Italyxxxx$ 809.48 Millionxxxx8.8%
Russiaxxxx$ 1458.94 Millionxxxx8.4%
Spainxxxx$ 771.83 Millionxxxx8.5%
Swedenxxxx$ 291.79 Millionxxxx9.5%
Denmarkxxxx$ 197.66 Millionxxxx9.2%
Switzerlandxxxx$ 141.19 Millionxxxx9.1%
Luxembourgxxxx$ 112.95 Millionxxxx9.7%
Rest of Europexxxx$ 1317.75 Millionxxxx8.1%
Asia Pacificxxxx$ 7789.68 Million$ 21021.8 Million13.2%
Chinaxxxx$ 3271.67 Millionxxxx12.7%
Japanxxxx$ 1074.98 Millionxxxx11.7%
South Koreaxxxx$ 934.76 Millionxxxx12.3%
Indiaxxxx$ 778.97 Millionxxxx15.1%
Australiaxxxx$ 405.06 Millionxxxx12.5%
Singaporexxxx$ 155.79 Millionxxxx13.5%
Taiwanxxxx$ 303.8 Millionxxxx13%
South East Asiaxxxx$ 514.12 Millionxxxx14%
Rest of APACxxxx$ 350.54 Millionxxxx13%
South Americaxxxx$ 1233.37 Million$ 2865 Million11.1%
Brazilxxxx$ 527.88 Millionxxxx11.7%
Argentinaxxxx$ 207.21 Millionxxxx12%
Colombiaxxxx$ 109.77 Millionxxxx10.9%
Peruxxxx$ 101.14 Millionxxxx11.3%
Chilexxxx$ 88.8 Millionxxxx11.4%
Rest of South Americaxxxx$ 198.57 Millionxxxx10.2%
Middle Eastxxxx$ 1298.28 Million$ 3151.5 Million11.7%
Qatarxxxx$ 103.86 Millionxxxx11.2%
Saudi Arabiaxxxx$ 456.99 Millionxxxx12%
Turkeyxxxx$ 103.86 Millionxxxx12.3%
UAExxxx$ 267.45 Millionxxxx12.2%
Egyptxxxx$ 77.9 Millionxxxx11.5%
Rest of Middle Eastxxxx$ 288.22 Millionxxxx10.9%
Africaxxxx$ 714.05 Million$ 1611.5 Million10.7%
Nigeriaxxxx$ 57.12 Millionxxxx10.9%
South Africaxxxx$ 251.35 Millionxxxx11.6%

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis


Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

Competitive Landscape of the Psoriasis Treatment Market

The Psoriasis Treatment Market is highly competitive, with major pharmaceutical companies investing heavily in R&D to develop more effective treatments with fewer side effects. Strategic partnerships, acquisitions, and expanding product portfolios are key strategies. Additionally, emerging players are focusing on innovative topical formulations and oral therapies, intensifying competition in both established and new market segments.

In October 2024, Innovent Biologics revealed the success of the Phase III trial of the use of IBI306 in treating psoriasis. In terms of efficacy, the study showed that the patients had better scores of psoriasis symptoms when compared to a placebo. Such data put forward IBI306 as a possible new treatment for patients with moderate to severe psoriasis.

https://www.innoventbio.com/InvestorsAndMedia/PressReleaseDetail?key=491 In October 2023, UCB launched its drug, BIMZELX for treating adults with moderate to severe psoriasis. This approval is derived from clinical evaluations showing that BIMZELX reduces psoriasis significantly as compared to other medications. https://www.ucb.com/newsroom/press-releases/article/bimzelxr-approved-by-the-us-fda-for-the-treatment-of-adults-with-moderate-to-severe-plaque-psoriasis

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
AbbVie Inc.••• ••• ••• •••
Amgen Inc.••• ••• ••• •••
Johnson & Johnson Services Inc.••• ••• ••• •••
Novartis AG••• ••• ••• •••
Eli Lilly and Company••• ••• ••• •••
AstraZeneca••• ••• ••• •••
Celgene Corporation••• ••• ••• •••
UCB S.A.••• ••• ••• •••
Merck••• ••• ••• •••
Boehringer Ingelheim International GmbH••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, the global Psoriasis Treatment market size will be USD 32457 million in 2025. It will expand at a compound annual growth rate (CAGR) of 10.40% from 2025 to 2033.

  • North America held the major market share for more than 40% of the global revenue with a market size of USD 12009.09 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2033.
  • Europe accounted for a market share of over 30% of the global revenue with a market size of USD 9412.53 million.
  • APAC held a market share of around 23% of the global revenue with a market size of USD 7789.68 million in 2025 and will grow at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2033.
  • South America has a market share of more than 5% of the global revenue with a market size of USD 1233.37 million in 2025 and will grow at a compound annual growth rate (CAGR) of 11.1% from 2025 to 2033.
  • The Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 1298.28 million in 2025. and will grow at a compound annual growth rate (CAGR) of 11.7% from 2025 to 2033.
  • Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 714.05 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2033.
  • TNF Inhibitors category is the fastest growing segment of the Psoriasis Treatment industry

 

Introduction of the Psoriasis Treatment Market

The Psoriasis Treatment Market is expanding rapidly due to the rising global prevalence of psoriasis, a chronic autoimmune disorder that causes the skin cells to multiply rapidly, leading to scaly, inflamed patches. The market encompasses a wide range of treatment options, including topical therapies, systemic treatments, and biologic therapies. Topical corticosteroids and vitamin D analogues are commonly used for mild-to-moderate cases, while biologics like TNF inhibitors and interleukin inhibitors are increasingly used for moderate-to-severe psoriasis. The market is also witnessing growth in oral medications like JAK inhibitors and new biologic-based topicals, which provide targeted, effective relief with fewer side effects. Ongoing advancements in personalized medicine and increased awareness about psoriasis are driving the demand for more tailored therapies. Additionally, rising healthcare investments, improved access to treatments, and a growing focus on patient-centric care are propelling market growth.

In October 2023, Arcutis Biotherapeutics, Inc., a biopharmaceutical company, received the US FDA approval for the Supplemental New Drug Application (sNDA) to expand the indication of Zoryve cream for tropically treating plaque psoriasis, comprising intertriginous areas, to children ages 6 to 11 years. https://www.arcutis.com/arcutis-submits-zoryve-roflumilast-cream-0-05-supplemental-new-drug-application-to-the-fda-for-the-treatment-of-children-aged-2-to-5-with-mild-to-moderate-atopic-dermatitis/

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Psoriasis Treatment Market Analysis is witnessing significant growth in the near future.

In 2023, the Topical Therapies segment accounted for a notable share of the Psoriasis Treatment Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst · Cognitive Market Research
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

The global market size for Psoriasis Treatment in 2025 is USD 32457 million.
The global Psoriasis Treatment market is expected to grow with a CAGR of 10.40% over the projected period.
North America held a significant global Psoriasis Treatment market revenue share in 2025.
Asia-Pacific will witness the fastest growth of the global Psoriasis Treatment market over the coming years.
The US had the most significant global Psoriasis Treatment market revenue share in 2025.
The main driver of the growth of the Psoriasis Treatment market is the increased awareness and early diagnosis and advancements in biologic and targeted therapies.
The Hospital Pharmacies category dominates the market.

★ Reviews

Rate this report

Psoriasis Treatment Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).

Drug Class Topical Therapies, Phototherapy, Systemic Non-Biologics, Biologics
Route of Administration Oral, Parenteral, Topical
Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
Psoriasis Type Plaque Psoriasis, Psoriatic Arthritis, Others
List of Competitors AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., Novartis AG, Eli Lilly and Company, AstraZeneca, Celgene Corporation, UCB S.A., Merck, Boehringer Ingelheim International GmbH

Additional data which we are providing for Psoriasis Treatment market

  • Therapy Access & Affordability
  • Treatment Pathway Evolution
  • Regulatory & Policy Dynamics
  • Patient-Centric Factors
  • Digital & Remote Care Integration
  • Market Structure & Competition
  • Pipeline & Innovation Trends
  • Healthcare Provider Landscape
  • Sustainability & ESG Angle
  • Future Outlook Considerations
  • Epidemiology
  • Investment and Funding Scenario
  • Key Events and Conferences
  • Pipeline Analysis

  • 1.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      1.1.1 Global Psoriasis Treatment Market Analysis by Key Players
    • 1.1.2 Top Players Ranking 2024
    • 1.1.3 New Product Launch Analysis
    • 1.1.4 Industry Mergers and Acquisition Analysis
  • 1.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.1 AbbVie Inc.
      • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.1.2 Business Overview
      • 1.2.1.3 Financials (Subject to data availability)
      • 1.2.1.4 R&D Investment (Subject to data availability)
      • 1.2.1.5 Product Types Specification
      • 1.2.1.6 Business Strategy
      • 1.2.1.7 Recent Developments
      • 1.2.1.8 Management Change
      • 1.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.2 Amgen Inc.
      • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.2.2 Business Overview
      • 1.2.2.3 Financials (Subject to data availability)
      • 1.2.2.4 R&D Investment (Subject to data availability)
      • 1.2.2.5 Product Types Specification
      • 1.2.2.6 Business Strategy
      • 1.2.2.7 Recent Developments
      • 1.2.2.8 Management Change
      • 1.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.3 Johnson & Johnson Services Inc.
      • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.3.2 Business Overview
      • 1.2.3.3 Financials (Subject to data availability)
      • 1.2.3.4 R&D Investment (Subject to data availability)
      • 1.2.3.5 Product Types Specification
      • 1.2.3.6 Business Strategy
      • 1.2.3.7 Recent Developments
      • 1.2.3.8 Management Change
      • 1.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.4 Novartis AG
      • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.4.2 Business Overview
      • 1.2.4.3 Financials (Subject to data availability)
      • 1.2.4.4 R&D Investment (Subject to data availability)
      • 1.2.4.5 Product Types Specification
      • 1.2.4.6 Business Strategy
      • 1.2.4.7 Recent Developments
      • 1.2.4.8 Management Change
      • 1.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.5 Eli Lilly and Company
      • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.5.2 Business Overview
      • 1.2.5.3 Financials (Subject to data availability)
      • 1.2.5.4 R&D Investment (Subject to data availability)
      • 1.2.5.5 Product Types Specification
      • 1.2.5.6 Business Strategy
      • 1.2.5.7 Recent Developments
      • 1.2.5.8 Management Change
      • 1.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.6 AstraZeneca
      • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.6.2 Business Overview
      • 1.2.6.3 Financials (Subject to data availability)
      • 1.2.6.4 R&D Investment (Subject to data availability)
      • 1.2.6.5 Product Types Specification
      • 1.2.6.6 Business Strategy
      • 1.2.6.7 Recent Developments
      • 1.2.6.8 Management Change
      • 1.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.7 Celgene Corporation
      • 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.7.2 Business Overview
      • 1.2.7.3 Financials (Subject to data availability)
      • 1.2.7.4 R&D Investment (Subject to data availability)
      • 1.2.7.5 Product Types Specification
      • 1.2.7.6 Business Strategy
      • 1.2.7.7 Recent Developments
      • 1.2.7.8 Management Change
      • 1.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.8 UCB S.A.
      • 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.8.2 Business Overview
      • 1.2.8.3 Financials (Subject to data availability)
      • 1.2.8.4 R&D Investment (Subject to data availability)
      • 1.2.8.5 Product Types Specification
      • 1.2.8.6 Business Strategy
      • 1.2.8.7 Recent Developments
      • 1.2.8.8 Management Change
      • 1.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.9 Merck
      • 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.9.2 Business Overview
      • 1.2.9.3 Financials (Subject to data availability)
      • 1.2.9.4 R&D Investment (Subject to data availability)
      • 1.2.9.5 Product Types Specification
      • 1.2.9.6 Business Strategy
      • 1.2.9.7 Recent Developments
      • 1.2.9.8 Management Change
      • 1.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      1.2.10 Boehringer Ingelheim International GmbH
      • 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 1.2.10.2 Business Overview
      • 1.2.10.3 Financials (Subject to data availability)
      • 1.2.10.4 R&D Investment (Subject to data availability)
      • 1.2.10.5 Product Types Specification
      • 1.2.10.6 Business Strategy
      • 1.2.10.7 Recent Developments
      • 1.2.10.8 Management Change
      • 1.2.10.9 S.W.O.T Analysis

  • 2.1 Global Psoriasis Treatment Market Analysis
  • 2.2 Global Psoriasis Treatment Market Analysis by Region
  • 2.3 Global Psoriasis Treatment Market Analysis by Drug Class
  • 2.4 Global Psoriasis Treatment Market Analysis by Route of Administration
  • 2.5 Global Psoriasis Treatment Market Analysis by Distribution Channel
  • 2.6 Global Psoriasis Treatment Market Analysis by Psoriasis Type
  • 2.7 Global Psoriasis Treatment Market Analysis by Key Players

  • 3.1 North America Psoriasis Treatment Market Analysis
  • 3.2 North America Psoriasis Treatment Market Analysis by Country
  • 3.3 North America Psoriasis Treatment Market Analysis by Drug Class
  • 3.4 North America Psoriasis Treatment Market Analysis by Route of Administration
  • 3.5 North America Psoriasis Treatment Market Analysis by Distribution Channel
  • 3.6 North America Psoriasis Treatment Market Analysis by Psoriasis Type
  • 3.7 North America Psoriasis Treatment Market Analysis by Key Players

  • 4.1 Europe Psoriasis Treatment Market Analysis
  • 4.2 Europe Psoriasis Treatment Market Analysis by Country
  • 4.3 Europe Psoriasis Treatment Market Analysis by Drug Class
  • 4.4 Europe Psoriasis Treatment Market Analysis by Route of Administration
  • 4.5 Europe Psoriasis Treatment Market Analysis by Distribution Channel
  • 4.6 Europe Psoriasis Treatment Market Analysis by Psoriasis Type
  • 4.7 Europe Psoriasis Treatment Market Analysis by Key Players

  • 5.1 Asia Pacific Psoriasis Treatment Market Analysis
  • 5.2 Asia Pacific Psoriasis Treatment Market Analysis by Country
  • 5.3 Asia Pacific Psoriasis Treatment Market Analysis by Drug Class
  • 5.4 Asia Pacific Psoriasis Treatment Market Analysis by Route of Administration
  • 5.5 Asia Pacific Psoriasis Treatment Market Analysis by Distribution Channel
  • 5.6 Asia Pacific Psoriasis Treatment Market Analysis by Psoriasis Type
  • 5.7 Asia Pacific Psoriasis Treatment Market Analysis by Key Players

  • 6.1 South America Psoriasis Treatment Market Analysis
  • 6.2 South America Psoriasis Treatment Market Analysis by Country
  • 6.3 South America Psoriasis Treatment Market Analysis by Drug Class
  • 6.4 South America Psoriasis Treatment Market Analysis by Route of Administration
  • 6.5 South America Psoriasis Treatment Market Analysis by Distribution Channel
  • 6.6 South America Psoriasis Treatment Market Analysis by Psoriasis Type
  • 6.7 South America Psoriasis Treatment Market Analysis by Key Players

  • 7.1 Middle East Psoriasis Treatment Market Analysis
  • 7.2 Middle East Psoriasis Treatment Market Analysis by Country
  • 7.3 Middle East Psoriasis Treatment Market Analysis by Drug Class
  • 7.4 Middle East Psoriasis Treatment Market Analysis by Route of Administration
  • 7.5 Middle East Psoriasis Treatment Market Analysis by Distribution Channel
  • 7.6 Middle East Psoriasis Treatment Market Analysis by Psoriasis Type
  • 7.7 Middle East Psoriasis Treatment Market Analysis by Key Players

  • 8.1 Africa Psoriasis Treatment Market Analysis
  • 8.2 Africa Psoriasis Treatment Market Analysis by Country
  • 8.3 Africa Psoriasis Treatment Market Analysis by Drug Class
  • 8.4 Africa Psoriasis Treatment Market Analysis by Route of Administration
  • 8.5 Africa Psoriasis Treatment Market Analysis by Distribution Channel
  • 8.6 Africa Psoriasis Treatment Market Analysis by Psoriasis Type
  • 8.7 Africa Psoriasis Treatment Market Analysis by Key Players

  • 9.1 Topical Therapies
    • 9.1.1 Global Topical Therapies Market
    • 9.1.2 Global Topical Therapies Market by Region
  • 9.2 Phototherapy
    • 9.2.1 Global Phototherapy Market
    • 9.2.2 Global Phototherapy Market by Region
  • 9.3 Systemic Non-Biologics
    • 9.3.1 Global Systemic Non-Biologics Market
    • 9.3.2 Global Systemic Non-Biologics Market by Region
  • 9.4 Biologics
    • 9.4.1 Global Biologics Market
    • 9.4.2 Global Biologics Market by Region

  • 10.1 Oral
    • 10.1.1 Global Oral Market
    • 10.1.2 Global Oral Market by Region
  • 10.2 Parenteral
    • 10.2.1 Global Parenteral Market
    • 10.2.2 Global Parenteral Market by Region
  • 10.3 Topical
    • 10.3.1 Global Topical Market
    • 10.3.2 Global Topical Market by Region

  • 11.1 Hospital Pharmacies
    • 11.1.1 Global Hospital Pharmacies Market
    • 11.1.2 Global Hospital Pharmacies Market by Region
  • 11.2 Retail Pharmacies
    • 11.2.1 Global Retail Pharmacies Market
    • 11.2.2 Global Retail Pharmacies Market by Region
  • 11.3 Online Pharmacies
    • 11.3.1 Global Online Pharmacies Market
    • 11.3.2 Global Online Pharmacies Market by Region
  • 11.4 Others
    • 11.4.1 Global Others Market
    • 11.4.2 Global Others Market by Region

  • 12.1 Plaque Psoriasis
    • 12.1.1 Global Plaque Psoriasis Market
    • 12.1.2 Global Plaque Psoriasis Market by Region
  • 12.2 Psoriatic Arthritis
    • 12.2.1 Global Psoriatic Arthritis Market
    • 12.2.2 Global Psoriatic Arthritis Market by Region
  • 12.3 Others
    • 12.3.1 Global Others Market
    • 12.3.2 Global Others Market by Region

  • 13.1 Market Drivers
  • 13.2 Market Restraints
  • 13.3 Market Trends
  • 13.4 Market Opportunity
  • 13.5 Technological Road Map (Subject to Data Availability)
  • 13.6 Product Life Cycle (Subject to Data Availability)
  • 13.7 Customer and Buyer Behavior Analysis
    • 13.7.1 Consumer Demographics and Target Audience Assessment
    • 13.7.2 Digital Engagement, Customer Experience & Relationship Analysis
    • 13.7.3 Customer Buying Behavior & Purchase Decision Analysis
    • 13.7.4 Vendor Selection, Supplier Preferences & Future Demand Trends
    • 13.7.5 Pricing, Affordability & Value Perception Analysis
    • 13.7.6 Customer Segmentation & Demand Pattern Analysis
  • 13.8 PESTEL Analysis
    • 13.8.1 Political Factors
    • 13.8.2 Economic Factors
    • 13.8.3 Social Factors
    • 13.8.4 Technological Factors
    • 13.8.5 Legal Factors
    • 13.8.6 Environmental Factors
  • 13.9 Industrial Chain Analysis (Subject to Data Availability)
    • 13.9.1 Industry Chain Analysis
    • 13.9.2 Manufacturing Cost Analysis
    • 13.9.3 Supply Side Analysis
      • 13.9.3.1 Raw Material Analysis
      • 13.9.3.2 Raw Material Procurement Analysis
      • 13.9.3.3 Raw Material Price Trend Analysis
  • 13.10 Porter’s Five Forces Analysis
    • 13.10.1 Bargaining Power of Suppliers
    • 13.10.2 Bargaining Power of Buyers
    • 13.10.3 Threat of New Entrants
    • 13.10.4 Threat of Substitutes
    • 13.10.5 Degree of Competition
  • 13.11 Patent Analysis (Subject to Data Availability)
  • 13.12 ESG Analysis
  • 13.13 Geopolitical Outlook
    • 13.13.1 Global Power Realignment & Strategic Alliances
    • 13.13.2 Geopolitical Risk Landscape & Conflict Hotspots
    • 13.13.3 International Trade Relations & Market Access Environment
    • 13.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
    • 13.13.5 Supply Chain Resilience, Localization & Resource Nationalism
    • 13.13.6 Technology Sovereignty & Digital Geopolitics
    • 13.13.7 Strategic Implications for Investment, Growth & Market Entry

  • This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy

    13.14 AI & Market Transformation
    • 13.14.1 Competitive Landscape Disruption & Strategic Shifts
    • 13.14.2 AI-Driven Transformation of Industry Value Chain
    • 13.14.3 Evolution of Business Models & Revenue Streams
    • 13.14.4 AI-Driven Product, Service & Innovation Transformation
    • 13.14.5 Customer Behavior, AI Adoption & Future Market Evolution

  • 14.1 Country 1
    • 14.2 Country 2
    • 14.3 Country 3
    • 14.4 Country 4
    • 14.5 Country 5
    • 14.6 Country 6
    • 14.7 Country 7
    • 14.8 Country 8
    • 14.9 Country 9
    • 14.10 Country 10

    • 15.1 Key Takeaways

    • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

      15.2 Analyst Point of View
    • 15.3 Assumptions and Acronyms

    • 16.1 Primary Data Collection
      • 16.1.1 Steps for Primary Data Collection
        • 16.1.1.1 Identification of KOL
      • 16.1.2 Backward Integration
      • 16.1.3 Forward Integration
      • 16.1.4 How Primary Research Help Us
      • 16.1.5 Modes of Primary Research
    • 16.2 Secondary Research
      • 16.2.1 How Secondary Research Help Us
      • 16.2.2 Sources of Secondary Research
    • 16.3 Data Validation
      • 16.3.1 Data Triangulation
    • 16.4 Data Representation

    Athenaeum AI Dashboard

    Research Framework · 70:30 Primary:Secondary

    Our Proprietary Methodology

    Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Psoriasis Treatment Market Analysis Market analysis.

    01

    Primary Intelligence Gathering

    Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

    02

    Secondary Data Triangulation

    Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

    03

    Expert Validation Protocol

    Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

    04

    Athenaeum AI Processing

    Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

    05

    Editorial & QA Review

    Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

    Data Assurance Metrics
    Data Points Validated 10,400+
    Expert Interviews 54
    Countries Covered 39+
    Company Profiles 10+
    Forecast Accuracy (Historical) 94.2%
    Report Pages 250+
    Analytical Coverage
    Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

    To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

    Latest News about Psoriasis Treatment Market

     17 Apr 2024 money.usnews.com

    J&J's Medical Device Sales Fall Short, Cancer Drugs Seen Growing

    Due in part to lower-than-expected sales of its popular psoriasis medication Stelara, Johnson & Johnson's first-quarter revenue for medical devices fell short of Wall Street projections. Due in large part to the high demand for Abiomed heart pumps and equipment used in wound closure procedures, the business reported $7.82 billion in sales for the quarter. This fell short of the $7.88 billion analysts had predicted. China-related concerns appeared to be a restraint on the poor performance of both divisions. J&J's stock was down 1.3% at $145.71, while the stocks of Medtronic, Stryker, and Zimmer Biomet—three major manufacturers of medical devices—were down roughly 1% as well. Wall Street predictions of $200 million for sales of the cancer medication Carvykti, which uses cell therapy, were not met. Since 2023, J&J has increased its cell processing manufacturing capacity by twofold. The company anticipates that Carvykti sales will continue to rise this year, especially in the second half. Sales of Stelara remained stagnant at $2.45 billion, missing experts' forecast of $2.6 billion.

    Read the source

    Sources from the Pharma & Healthcare Industry

    How We Serve You

    The Three Pillars of End-to-End Market Research Services

    We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Psoriasis Treatment Market Analysis market.

    Service 01

    Market Survey

    B2B B2C

    Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the psoriasis treatment market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

    What's Included
    • Buyer intent & sentiment analysis
    • Purchase cycle mapping
    • Price sensitivity research
    • Channel preference profiling
    • Competitive perception study
    Most Requested
    Service 02

    Customized Market Data & Reports

    Custom Ready Report

    Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

    What's Included
    • Ready syndicate report (250+ pages)
    • Custom data scope & segmentation
    • Excel quantitative models
    • Board-ready PPT with key findings
    • Secure cloud portal access
    Service 03

    Strategic Consultation

    With Survey With Report

    Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

    What's Included
    • Dedicated analyst assigned to you
    • Live walkthrough of findings
    • Strategic Q&A sessions
    • Go-to-market recommendations
    • NDA-protected engagement

    Customize This Report

    Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.